ELEKTA UNSP ADR EACH REPR 1 ORD (EKTAY) Financials
EKTAY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-01-31 | 3.0 billion | 2.0 billion |
| 2023-10-31 | 2.9 billion | 1.9 billion |
| 2023-07-31 | 2.9 billion | 2.0 billion |
| 2023-04-30 | 2.9 billion | 1.9 billion |
EKTAY Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-01-31 | 60.7 million | ? |
| 2023-10-31 | 19.0 million | ? |
| 2023-07-31 | -85.1 million | ? |
| 2023-04-30 | 153.4 million | 2.4 million |
EKTAY Net Income
| Date | Net Income |
|---|---|
| 2024-01-31 | 29.4 million |
| 2023-10-31 | 39.9 million |
| 2023-07-31 | 28.9 million |
| 2023-04-30 | 67.1 million |
EKTAY Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-01-31 | 226.0 million | - | 123.2 million |
| 2023-10-31 | 168.5 million | - | 93.9 million |
| 2023-07-31 | 224.6 million | - | 90.0 million |
| 2023-04-30 | 318.8 million | - | 92.4 million |
EKTAY Shares Outstanding
EKTAY Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-01-31 | 42.3 million | 32.8 million | 33.3 million | 35.5 million |
| 2023-10-31 | 37.1 million | 29.1 million | 30.9 million | 38.5 million |
| 2023-07-31 | 32.8 million | 36.6 million | 29.8 million | 41.2 million |
| 2023-04-30 | 40.8 million | 29.7 million | 31.7 million | 38.9 million |
EKTAY Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-01-31 | 436.0 million | 276.2 million |
| 2023-10-31 | 426.7 million | 273.8 million |
| 2023-07-31 | 363.2 million | 212.4 million |
| 2023-04-30 | 499.6 million | 311.4 million |
EKTAY
Price: $7.63
Dividend Yield: 0.34%
Forward Dividend Yield: 3.01%
Payout Ratio: 65.49%
Dividend Per Share: 0.23 USD
Earnings Per Share: 0.35 USD
P/E Ratio: 21.01
Exchange: PNK
Sector: Healthcare
Industry: Medical Instruments & Supplies
Market Capitalization: 2.8 billion
Average Dividend Frequency: 2
Years Paying Dividends: 14
DGR3: 30.00%
DGR5: 30.00%
DGR10: 30.00%